Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

CoCensys, Inc. (now Purdue)

CoCensys was a biotechnology company focused on therapeutics for central nervous system diseases and disorders. Their technology revolved around special receptor technology to modulate the chemical messengers that carry signals among neurons. CoCensys was acquired by Purdue Pharma.

Search Projects

  • Director, Clinical Research